| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/24/2004 | EP1399441A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 03/24/2004 | EP1399440A1 5-(2-aminopyrimidin-4-yl)benzisoxazoles as protein kinase inhibitors |
| 03/24/2004 | EP1399439A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 03/24/2004 | EP1399433A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 03/24/2004 | EP1399432A1 Spiropiperidine compounds as ligands for orl-1 receptor |
| 03/24/2004 | EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 03/24/2004 | EP1399430A1 Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor |
| 03/24/2004 | EP1399420A2 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 03/24/2004 | EP1399406A2 Novel estrogen receptor ligands and methods i |
| 03/24/2004 | EP1399190A1 Pharmaceutical compositions comprising low-solubility and/or acid-sensitive drugs and neutralized acidic polymers |
| 03/24/2004 | EP1399171A1 Medicinal herbal compounds for the prevention and treatment of diabetes |
| 03/24/2004 | EP1399166A1 A PHARMACEUTICAL COMBINATION COMPRISING EITHER (S)-2-ETHOXY-3- 4-(2- 4-METHANE SULFONYL OXYPHENYL ETHOXY) PHENYL] PROPANOIC ACID OR 3- 4- 2-(4-TERT- BUTOXY CARBONYL AMINOPHENYL) ETHOXY] PHENYL -(s)-2-ETHOXY PROPANOIC ACID AND A SULONYLUREA |
| 03/24/2004 | EP1399165A2 Stabilized dispersion of phytosterol in oil |
| 03/24/2004 | EP1399162A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels |
| 03/24/2004 | EP1399156A2 Alkylidene pirazolidinedione derivatives and their use for treating diabetes and obesity |
| 03/24/2004 | EP1399155A2 Small molecules useful in the treatment of inflammatory disease |
| 03/24/2004 | EP1399154A1 3-fluoro-pyrrolidines as antidiabetic agents |
| 03/24/2004 | EP1399153A2 Pharmaceutical composition comprising a drug and a fatty acid or salt thereof |
| 03/24/2004 | EP1399152A1 Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid ester |
| 03/24/2004 | EP1399150A1 Vitamin c compositions |
| 03/24/2004 | EP1399142A1 Use of acetyl l-carnitine in association with the biotin for the treatment of patients with type 2 insulin-resistant diabetes mellitus |
| 03/24/2004 | EP1399138A1 Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate |
| 03/24/2004 | EP1399137A1 Sulfonamides |
| 03/24/2004 | EP1399136A2 Process for the preparation of dispersions |
| 03/24/2004 | EP1399130A1 Emulsion and dispersion formulations and method |
| 03/24/2004 | EP1349558A4 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 03/24/2004 | EP1303517B1 Indoloquinazolinones |
| 03/24/2004 | EP1252164B1 Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid |
| 03/24/2004 | EP1214296B1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 03/24/2004 | EP1197493B1 Benzimidazole compounds |
| 03/24/2004 | EP1196416B1 Substituted purine derivatives as inhibitors of cell adhesion |
| 03/24/2004 | EP1173437B1 Thiazolidinedione derivative and its use as antidiabetic |
| 03/24/2004 | EP1143964B1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission |
| 03/24/2004 | EP1124809B1 Benzoylpyridazines |
| 03/24/2004 | EP1113726B1 Use of neohesperidin dihydrochalcone for the manufacture of a medicament for preventing or treating elevated blood lipid level-related diseases |
| 03/24/2004 | EP1082110B1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/24/2004 | EP0912543B1 Crystalline (-)-3r,4r-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-[4- 2-(pyrrolidin-1-yl)ethoxy]phenyl chromane, hydrogen fumarate |
| 03/24/2004 | EP0904079B1 Antidiabetic agents |
| 03/24/2004 | CN1484652A Antibodies to human IL-1 beta |
| 03/24/2004 | CN1484650A Urocortin proteins and uses thereof |
| 03/24/2004 | CN1484644A Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/24/2004 | CN1484524A 5-HT IA veceptor subtype agonist |
| 03/24/2004 | CN1483801A Health care wine containing dihydro-myricetin and myricetin composition |
| 03/24/2004 | CN1483782A Adhesive |
| 03/24/2004 | CN1483444A Formula of rehmannia root effervescence preparation and process for preparing same |
| 03/24/2004 | CN1483429A Medicine for treat hyperlipemia |
| 03/24/2004 | CN1483422A Medicine for treating diabetes |
| 03/24/2004 | CN1483418A Fat-reducing tea and preparation method trereof |
| 03/24/2004 | CN1483411A Licorzinc solution composition, preparation process thereof and licorzinc preparation |
| 03/24/2004 | CN1483401A Slow-released preparation |
| 03/24/2004 | CN1483327A Health care food containing dihydromyricetin and myricetin composition |
| 03/24/2004 | CN1142928C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/24/2004 | CN1142920C Quinazoline derivatives and pharmaceutical compositions containing them and preparation process and use |
| 03/24/2004 | CN1142913C Tetrahydroisoquinolinealkanol derivatives and pharmaceutical compositions contg. same |
| 03/24/2004 | CN1142912C Amide derivs, useful as inhibitors for production of cytokines |
| 03/24/2004 | CN1142902C Alk (En)yl dicarboxylic acid bisesters, their use and method for preparing them |
| 03/24/2004 | CN1142784C Process for preparing protein extracts |
| 03/24/2004 | CN1142778C Use of thiazolium compounds for preventing and preventing the formation of advanced glycosylation endproducts |
| 03/24/2004 | CN1142753C Skin patches for providing testosterone |
| 03/24/2004 | CN1142724C Two-stage preparation |
| 03/23/2004 | US6710167 Purifying insulin using stationary phase comprising pressure stable organic polymeric chromatography material and mobile phase comprising at least one water miscible organic solvent and at least one buffer substance, having ph from 7 to 11 |
| 03/23/2004 | US6710088 Inorganic ion receptor-active compounds |
| 03/23/2004 | US6710087 For therapy and prophylaxis of disorders that are ameliorated by the inhibition of neuronal monoamine uptake in mammals; disorders including erectile dysfunction, affective disorders, obesity, cerebral function disorders, pain |
| 03/23/2004 | US6710069 1-aryl- or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 03/23/2004 | US6710067 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/23/2004 | US6710063 Activators of PPAR delta |
| 03/23/2004 | US6710059 Methods of treating and/or suppressing weight gain |
| 03/23/2004 | US6710054 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/23/2004 | US6710050 Pharmaceutical composition and the process for its preparation |
| 03/23/2004 | US6710026 Diabetes |
| 03/23/2004 | US6709864 Composition comprising isolated human mesenchymal stem cells in biocompatible matrix which supports differentiation and maturation of stem cells into adipocytes |
| 03/23/2004 | US6709831 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 03/23/2004 | US6709668 Hydrogel-forming system with hydrophobic and hydrophilic components |
| 03/23/2004 | US6709595 Solvent extraction at supercritical pressure |
| 03/23/2004 | CA2263319C Quinazoline derivatives and pharmaceutical compositions containing them |
| 03/18/2004 | WO2004023100A2 Cd56 positive human adult pancreatic endocrine progenitor cells |
| 03/18/2004 | WO2004022772A2 Modulation of the synthesis of insulin |
| 03/18/2004 | WO2004022716A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | WO2004022582A1 Peptidomimetic drugs |
| 03/18/2004 | WO2004022553A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING IκB KINASE |
| 03/18/2004 | WO2004022551A1 Furan or thiophene derivative and medicinal use thereof |
| 03/18/2004 | WO2004022544A1 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same |
| 03/18/2004 | WO2004022536A1 New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 03/18/2004 | WO2004022533A1 Novel vinyl carboxylic acid derivatives and their therapeutical use |
| 03/18/2004 | WO2004022526A1 Cathepsin cysteine protease inhibitors |
| 03/18/2004 | WO2004022091A1 Diacylglycerol production promoter |
| 03/18/2004 | WO2004022090A1 A method of modulating endothelial cell activity |
| 03/18/2004 | WO2004022089A1 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 03/18/2004 | WO2004022086A1 Adrenocortical hormone secretion controller |
| 03/18/2004 | WO2004022083A1 A nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction |
| 03/18/2004 | WO2004022076A1 Branched alpha-glucans for weight management |
| 03/18/2004 | WO2004022074A1 Nutritional compositions comprising a non-glucose carbohydrate or pectin and soluble fiber |
| 03/18/2004 | WO2004022053A1 Atorvastatin calcium form vi or hydrates thereof |
| 03/18/2004 | WO2004022032A2 Pharmaceutical dosage form comprising a sulfite compound |
| 03/18/2004 | WO2004021984A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 03/18/2004 | WO2004021973A2 Pravastatin pharmaceutical formulations and methods of their use |
| 03/18/2004 | WO2004012733A3 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 03/18/2004 | WO2004009596A3 Pyrazolopyrimidines as kinase inhibitors |
| 03/18/2004 | WO2004002239A3 Purified amylase inhibitor and novel process for obtaining the same |
| 03/18/2004 | WO2004000204A8 Labelled somatostatin analogs backbone cyclized through metal complexation |